An observational study in IUGR, sponsored by Karadeniz Technical University. Enrolling by invitation at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.
Sponsored by Karadeniz Technical University · Observational
**Brief Summary**
This study aims to evaluate the relationship between fetuin-B levels and intrauterine growth restriction (IUGR). Maternal serum fetuin-B levels will be compared between pregnant women with IUGR and those with appropriate fetal growth. The study will also assess whether fetuin-B levels are associated with clinical and obstetric characteristics, fetal growth parameters, and Doppler findings. The findings may provide further insight into the potential role of fetuin-B in the pathophysiology and clinical assessment of IUGR.
Karadeniz Technical University is the lead sponsor of 150 studies on the registry; 19 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study population will consist of pregnant women with singleton pregnancies who are evaluated during pregnancy at the participating center. The study group will include pregnant women diagnosed with intrauterine growth restriction (IUGR) according to predefined fetal growth and Doppler criteria. The control group will consist of pregnant women with appropriate-for-gestational-age (AGA) fetuses without evidence of IUGR. Maternal serum samples will be collected from participants to measure fetuin-B levels, and clinical, obstetric, fetal biometric, and Doppler parameters will be evaluated.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pregnant women diagnosed with intrauterine growth restriction (IUGR) according to established clinical and ultrasonographic criteria. Maternal serum fetuin-B levels, fetal growth parameters, and Doppler findings will be evaluated.
Other: measure fetuin b
Pregnant women with appropriate-for-gestational-age (AGA) fetuses and without evidence of intrauterine growth restriction. Maternal serum fetuin-B levels, fetal growth parameters, and Doppler findings will be evaluated.
Other: measure fetuin b
No intervention is administered. This is an observational study in which maternal serum fetuin-B levels are measured and compared between pregnant women with intrauterine growth restriction (IUGR) and pregnant women with appropriate-for-gestational-age (AGA) fetuses.
Maternal Serum Fetuin-B Level
Maternal serum fetuin-B levels will be measured and compared between pregnant women with intrauterine growth restriction (IUGR) and pregnant women with appropriate-for-gestational-age (AGA) fetuses to evaluate the association between fetuin-B levels and IUGR.
Time frame: At the time of diagnosis of IUGR or at the corresponding gestational age in the control group. It is time between the 24th and 37th weeks of pregnancy.
Plan to share: No — No. Individual participant-level data will not be made available to other researchers.
No publications or documents are linked to this record.
Start is estimated for Oct 2026; primary completion for Jan 2027, 3 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karadeniz Technical University →